Cours Cell MedX Corp. Other OTC
Actions
CMXC
US15115X1072
Recherche biotechnologique et médicale
CA 2022 | 0,01 0,01 | CA 2023 | 0 0 | Capitalisation | 6,29 k 5,72 k |
---|---|---|---|---|---|
Résultat net 2022 | - 0 | Résultat net 2023 | - 0 | VE / CA 2022 | 1 135 153 669 x |
Dette nette 2022 | 592 k 539 k | Dette nette 2023 | 903 k 821 k | VE / CA 2023 | 329 116 944 x |
PER 2022 |
-9,01
x | PER 2023 |
-0,01
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 20,34% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 45 | 24/11/14 |
George Adams
CHM | Chairman | 76 | 23/03/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27/04/22 |
Joao da Costa
BRD | Director/Board Member | 59 | 08/06/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,28% | 42,68 Md | |
-3,99% | 42,4 Md | |
+45,32% | 40,04 Md | |
-6,20% | 28,31 Md | |
+6,36% | 24,94 Md | |
-21,47% | 18,96 Md | |
+27,58% | 12,3 Md | |
-2,75% | 11,95 Md | |
-2,02% | 11,55 Md |